Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of July 2025
The US FDA has approved a total of 6 new drugs, including 5 new molecular entities and 1 biologic, leading to the treatment of patients and advances in the pharmaceutical industry
The major highlighted drug was Regeneron’s Lynozyfic, securing…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of May 2025
The US FDA has approved a total of 3 new drugs, including 2 new molecular entities and 1 Biologic leading to the treatment of patients and advances in the healthcare industry
The major highlighted drug was AbbVie’s Emrelis securing…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of July 2024
The US FDA approved a total of 2 new drugs including 1 new molecular entity and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was Eli Lilly’s Kisunla for…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of June 2024
The US FDA approved a total of 5 new drugs including 4 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was Ipsen’s Iqirvo for the treatment…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of May 2024
The US FDA approved a total of 3 new drugs including 2 new molecular entities and 1 biologic leading to treatments for patients and advances in the healthcare industry
The major highlighted drug was Amgen’s Imdelltra for the treatment…
Shots:
PharmaShots has compiled a list of US FDA-approved drugs in the month of April 2024
The US FDA approved a total of 12 new drugs including 11 new molecular entities and 1 biologic leading to the treatments for patients and advances in the healthcare industry
The major highlighted drug was X4 Pharmaceuticals’ Xolremdi for…

